IMA201-101

IMA201 TCR-engineered T cells · Immatics US, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMA201-101, covering 2025-02-04 to 2025-02-04. Get the full timeline:

Most recent: Clinical Trial Update: TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) [Phase 1]